View By:
August 31 – September 1
Display of Antibodies
Antibodies for Cancer Therapy
Improving Immunotherapy Efficacy and Safety
Difficult-to-Express Proteins
Characterization for Novel Biotherapeutics
Immunogenicity Case Studies and Clinical Management
Emerging Indications for Therapeutic Antibodies
September 1
Overview of Biologic COVID-19 Interventions
September 2-3
Engineering Antibodies
Advancing Bispecific Antibodies and Combination Therapy to the Clinic
CAR Ts, TCRs and TILs
Biophysical Methods
Optimizing Protein Expression
Immunogenicity Assessment and Regulatory Approval of Biologics
Engineering Antibody-Drug Conjugates
Gene Therapy
September 3-4
Engineering Bispecific Antibodies
Clinical Progress of Antibody-Drug Conjugates
Agonist Immunotherapy Targets
Cell and Gene Therapy Analytics
Protein Expression System Engineering
Optimizing Bioassays for Biologics